Abstract
BackgroundUse of glucocorticosteroids and NSAIDS for the treatment of RA has been associated with an increased risk of gastrointestinal (GI) perforations. The introduction of disease modifying agents, such as methotrexate...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
